Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in Vietnamese Patients with CHD
NCT01757262Phase 3Withdrawn
- Sponsor
- AstraZeneca
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ticagrelor in coronary heart disease (CHD), sponsored by AstraZeneca. Planned start Jan 2013; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT01757262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757262.